Veda N Giri

Veda N Giri

UNVERIFIED PROFILE

Are you Veda N Giri?   Register this Author

Register author
Veda N Giri

Veda N Giri

Publications by authors named "Veda N Giri"

Are you Veda N Giri?   Register this Author

43Publications

883Reads

38Profile Views

Introduction to the 2019 Philadelphia Prostate Cancer Consensus Program: 'Implementation of Genetic Testing for Inherited Prostate Cancer'.

Can J Urol 2019 Oct;26(5S2):1-4

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
October 2019

Genetic education and practice considerations of non-genetic providers.

Authors:
Veda N Giri

Can J Urol 2019 Oct;26(5S2):44-45

Departments of Medical Oncology, Cancer Biology and Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
October 2019

Exploring Asian Indian views about cancer and participation in cancer research: an evaluation of a culturally tailored educational intervention.

J Community Genet 2019 Sep 14. Epub 2019 Sep 14.

Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12687-019-00436-5DOI Listing
September 2019

Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.

Eur Urol Oncol 2019 Jul 2. Epub 2019 Jul 2.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; Cancer Risk Assessment and Clinical Cancer Genetics, Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311193008
Publisher Site
http://dx.doi.org/10.1016/j.euo.2019.06.010DOI Listing
July 2019

Diet assessment among men undergoing genetic counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention.

Prostate 2019 May 24;79(7):778-783. Epub 2019 Mar 24.

Cancer Risk Assessment and Clinical Cancer Genetics Program, Departments of Medical Oncology, Cancer Biology, and Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23783DOI Listing
May 2019

Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.

Prostate 2018 09 14;78(12):879-888. Epub 2018 Apr 14.

Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047906PMC
September 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

Exploring Asian Indian and Pakistani views about cancer and participation in cancer genetics research: toward the development of a community genetics intervention.

J Community Genet 2018 Jan 28;9(1):27-35. Epub 2017 Jun 28.

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12687-017-0312-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752649PMC
January 2018

The Role of Genetic Counseling in Familial and Sporadic Cancer: Considerations, Challenges, and Collaboration.

Ann Intern Med 2017 12 31;167(12):884-885. Epub 2017 Oct 31.

From Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, Pennsylvania; Dana-Farber Cancer Institute, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://annals.org/article.aspx?doi=10.7326/M17-2512
Publisher Site
http://dx.doi.org/10.7326/M17-2512DOI Listing
December 2017

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

J Genet Couns 2017 Jun 19;26(3):548-555. Epub 2017 Jan 19.

Cancer Risk Assessment and Clinical Cancer Genetics Program, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-016-0020-4DOI Listing
June 2017

HOXB13 and other high penetrant genes for prostate cancer.

Asian J Androl 2016 Jul-Aug;18(4):530-2

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School and The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://www.ajandrology.com/text.asp?2016/18/4/530/175785
Publisher Site
http://dx.doi.org/10.4103/1008-682X.175785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955175PMC
March 2017

Familial prostate cancer.

Semin Oncol 2016 Oct 18;43(5):560-565. Epub 2016 Aug 18.

Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine Department of Oncology, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.08.001DOI Listing
October 2016

How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.

Can J Urol 2016 Apr;23(2):8247-53

Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2016

Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project.

J Cancer Educ 2016 Mar;31(1):191-7

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, 1025 Walnut Street, Room 1015, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-015-0854-8DOI Listing
March 2016

Interest in genomic SNP testing for prostate cancer risk: a pilot survey.

Hered Cancer Clin Pract 2015 8;13(1):11. Epub 2015 Apr 8.

Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13053-015-0032-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396119PMC
April 2015

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Authors:
Elizabeth K Bancroft Elizabeth C Page Elena Castro Hans Lilja Andrew Vickers Daniel Sjoberg Melissa Assel Christopher S Foster Gillian Mitchell Kate Drew Lovise Mæhle Karol Axcrona D Gareth Evans Barbara Bulman Diana Eccles Donna McBride Christi van Asperen Hans Vasen Lambertus A Kiemeney Janneke Ringelberg Cezary Cybulski Dominika Wokolorczyk Christina Selkirk Peter J Hulick Anders Bojesen Anne-Bine Skytte Jimmy Lam Louise Taylor Rogier Oldenburg Ruben Cremers Gerald Verhaegh Wendy A van Zelst-Stams Jan C Oosterwijk Ignacio Blanco Monica Salinas Jackie Cook Derek J Rosario Saundra Buys Tom Conner Margreet G Ausems Kai-ren Ong Jonathan Hoffman Susan Domchek Jacquelyn Powers Manuel R Teixeira Sofia Maia William D Foulkes Nassim Taherian Marielle Ruijs Apollonia T Helderman-van den Enden Louise Izatt Rosemarie Davidson Muriel A Adank Lisa Walker Rita Schmutzler Kathy Tucker Judy Kirk Shirley Hodgson Marion Harris Fiona Douglas Geoffrey J Lindeman Janez Zgajnar Marc Tischkowitz Virginia E Clowes Rachel Susman Teresa Ramón y Cajal Nicholas Patcher Neus Gadea Allan Spigelman Theo van Os Annelie Liljegren Lucy Side Carole Brewer Angela F Brady Alan Donaldson Vigdis Stefansdottir Eitan Friedman Rakefet Chen-Shtoyerman David J Amor Lucia Copakova Julian Barwell Veda N Giri Vedang Murthy Nicola Nicolai Soo-Hwang Teo Lynn Greenhalgh Sara Strom Alex Henderson John McGrath David Gallagher Neil Aaronson Audrey Ardern-Jones Chris Bangma David Dearnaley Philandra Costello Jorunn Eyfjord Jeanette Rothwell Alison Falconer Henrik Gronberg Freddie C Hamdy Oskar Johannsson Vincent Khoo Zsofia Kote-Jarai Jan Lubinski Ulrika Axcrona Jane Melia Joanne McKinley Anita V Mitra Clare Moynihan Gad Rennert Mohnish Suri Penny Wilson Emma Killick Sue Moss Rosalind A Eeles

Eur Urol 2014 Sep 15;66(3):489-99. Epub 2014 Jan 15.

Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105321PMC
September 2014

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2014 Sep;12(9):1211-9; quiz 1219

From UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Massachusetts General Hospital Cancer Center; The University of Texas MD Anderson Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; City of Hope Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Dana-Farber/Brigham and Women's Cancer Center; Huntsman Cancer Institute at the University of Utah; University of Colorado Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Moffitt Cancer Center; Duke Cancer Institute; University of Alabama at Birmingham Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0120DOI Listing
September 2014

Gene panel testing for inherited cancer risk.

J Natl Compr Canc Netw 2014 Sep;12(9):1339-46

From Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Department of Internal Medicine, Division of Human Genetics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio; Clinical and Translational Hereditary Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; and Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0128DOI Listing
September 2014

Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.

J Genet Couns 2014 Jun 7;23(3):371-6. Epub 2013 Dec 7.

Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-013-9672-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028414PMC
June 2014

Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.

BJU Int 2014 May 13;113(5b):E150-6. Epub 2013 Aug 13.

Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830710PMC
May 2014

Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program.

Cancer 2012 Jan 12;118(2):478-84. Epub 2011 Jul 12.

Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195866PMC
January 2012

A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.

Cancer Epidemiol Biomarkers Prev 2011 Aug 29;20(8):1599-610. Epub 2011 Jun 29.

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-11-0312DOI Listing
August 2011

Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.

BJU Int 2011 Feb 24;107(3):466-70. Epub 2010 Aug 24.

Cancer Prevention and Control Program, Department of Clinical Genetics, Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09522.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052292PMC
February 2011

EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.

Breast Cancer Res Treat 2008 Jan 24;107(2):235-42. Epub 2007 Apr 24.

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0602, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9542-7DOI Listing
January 2008

Prostate cancer risk assessment program: a 10-year update of cancer detection.

J Urol 2007 Nov 17;178(5):1920-4; discussion 1924. Epub 2007 Sep 17.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19012, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.07.010DOI Listing
November 2007